Center for Biobehavioral Health

Vulnerable Population Lacks Access to Beneficial Puberty-Blocking Hormone Therapy

Transgender youth are often denied access to puberty-blocking hormones because insurance companies decline to cover costs, according to a new study.
October 17, 2017  |  Written by